Get 20% lifetime commission for referring investors to digrin.com
here.
Nautilus Biotechnolgy, Inc. ( NAUT) - Key Metrics
NAUT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.11 | -$0.11 | -$0.11 |
| 2026Q1 | $0 | -$0.12 | -$0.10 | -$0.11 |
| 2025Q4 | $0 | -$0.11 | -$0.10 | -$0.10 |
| 2025Q3 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2025Q2 | $0 | -$0.12 | -$0.11 | -$0.11 |
NAUT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.25 |
| 2026Q1 | 0% | -8.08 |
| 2025Q4 | 0% | -4.43 |
| 2025Q3 | 0% | -1.92 |
| 2025Q2 | 0% | -1.51 |
NAUT
Price: $0.85
52 week price:
Earnings Per Share: -0.45 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 189600
Market Capitalization: 112.8 million